Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation

Annals of Hematology

Volumn 87, Issue 12, 2008, Pages 1021-1022

  Stölzel, Friedrich ^a   Babatz, J ^a   Thiede, C ^a   Siegert, G ^a   Illmer, T ^a   Ehninger, G ^a   Schaich, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CASPOFUNGIN; CEFTAZIDIME; CYTARABINE; JANUS KINASE 2; LINEZOLID; MOXIFLOXACIN; PHENYLALANINE; PHOSPHATE; PREDNISOLONE; PROCALCITONIN; VALINE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; BONE MARROW BIOPSY; CASE REPORT; DISEASE DURATION; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; HOMOZYGOSITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LETTER; MALE; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; PATIENT TRANSPORT; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLENECTOMY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA;

BIOLOGICAL MARKERS; CALCITONIN; FEVER; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; MYELOFIBROSIS; POLYCYTHEMIA; PROTEIN PRECURSORS;

EID: 55649087781     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0517-5     Document Type: Letter

References (6)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (2002) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
2. Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323:17-29, Medline DOI 10.1016/S0009-8981(02)00101-8
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518, Medline DOI 10.1016/0140-6736(93)90277-N
4. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U et al (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134:49-55, Medline DOI 10.1016/ S0022-2143(99)90053-7
5. Ho CL, Lasho TL, Butterfield JH, Tefferi A (2007) Global cytokine analysis in myeloproliferative disorders. Leuk Res 31:1389-1392, Medline DOI 10.1016/j.leukres.2006.12.024
6. Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255-1265, Medline DOI 10.1056/NEJM200004273421706